ADGRA1-AS1

Across TCGA pan-cancer cohorts, ADGRA1-AS1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated ADGRA1-AS1 data layer compared with 13 for mass-spec protein.

The strongest signal is observed in cervical squamous cell carcinoma and endocervical adenocarcinoma (CESC), where higher ADGRA1-AS1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated ADGRA1-AS1 expression acts as an unfavorable survival marker.

CESC and KIRP are the cancer types where ADGRA1-AS1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CESC	OS	Median	III,IV	0.167	0.657	.044	6	view →
KIRP	OS	Median	All	0.248	0.705	.049	2	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

ADGRA1-AS1–CESC (OS)

Open the CESC breakdown →